BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, December 21, 2025
Home » Authors » John Fox

Articles by John Fox

Secretory structure clues may lead to antibiotics aimed at biofilms

Dec. 9, 2014
By John Fox
HONG KONG — The elucidation of the core structure of a secretory channel in the bacterial outer membrane may provide a target for the development of novel antibiotics aimed at attenuating biofilm formation, Chinese scientists report in the Dec. 1, 2014, early online edition of the Proceedings of the National Academy of Sciences.
Read More

Immune cell discovery may lead to new MS treatments

Dec. 4, 2014
By John Fox
HONG KONG – The breakthrough discovery of a new type of immune cells may play a key role in development of a treatment for multiple sclerosis (MS), a multi-disciplinary National University of Singapore (NUS) research team reported in Cell Research.
Read More

Metformin shows promise as an adjunctive TB therapy

Nov. 26, 2014
By John Fox
HONG KONG – The anti-diabetic drug, metformin, is a promising candidate for an effective adjunctive host therapy for boosting the efficacy of current tuberculosis (TB) treatments, Singapore Immunology Network (SIgN) researchers with the Agency for Science, Technology and Research (A*STAR) reported in the Nov. 19, 2014, edition of Science Translational Medicine.
Read More

Metformin shows promise as an adjunctive TB therapy

Nov. 24, 2014
By John Fox
HONG KONG – The anti-diabetic drug, metformin, is a promising candidate for an effective adjunctive host therapy for boosting the efficacy of current tuberculosis (TB) treatments, Singapore Immunology Network (SIgN) researchers with the Agency for Science, Technology and Research (A*STAR) reported in the Nov. 19, 2014, edition of Science Translational Medicine.
Read More

Adaptability of enterics may prove key to new treatments, study says

Nov. 19, 2014
By John Fox
HONG KONG - Researchers from the Riken Institute in Japan have discovered a mechanism through which the enteric Enterobacteriaceae bacteria can adjust to the very different oxygen environments within and outside of the human gut, an important finding that could represent a new drug target and ultimately lead to the development of new antimicrobials.
Read More

Gene discovery clue to infertility treatments

Nov. 12, 2014
By John Fox
HONG KONG - A team of Japanese scientists has discovered a new single gene mutation that can cause infertility, which not only sheds new light on the causes of that condition, but could also lead to its early detection and treatment based on genetic diagnosis.
Read More

Gene discovery clue to infertility treatments

Nov. 12, 2014
By John Fox
HONG KONG - A team of Japanese scientists has discovered a new single gene mutation that can cause infertility, which not only sheds new light on the causes of that condition, but could also lead to its early detection and treatment based on genetic diagnosis.
Read More

Study sheds light on cancer prevention and immunotherapy

Nov. 5, 2014
By John Fox
HONG KONG – Researchers from the Li Ka Shing Faculty of Medicine at The University of Hong Kong (HKU) have developed a DNA vaccine against malignant mesothelioma that elicited complete and long-lasting protection against malignancy, while curing pre-existing tumors in mouse models.
Read More

Study sheds light on cancer prevention and immunotherapy

Nov. 4, 2014
By John Fox
HONG KONG – Researchers from the Li Ka Shing Faculty of Medicine at The University of Hong Kong (HKU) have developed a DNA vaccine against malignant mesothelioma that elicited complete and long-lasting protection against malignancy, while curing pre-existing tumors in mouse models.
Read More

Transplanted stem cells release dopamine in PD model, study shows

Oct. 29, 2014
By John Fox
HONG KONG – Chinese researchers have demonstrated that grafted neural stem cells directly release dopamine into the damaged striata of rat brains in vivo and partially rescued a model of Parkinson's disease (PD), providing proof of concept for the feasibility of that technique for treating PD in humans.
Read More
Previous 1 2 … 59 60 61 62 63 64 65 66 67 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing